Market Research Blog – Page 1440 – New Product Development

Global Antibody Therapy Market Poised for Remarkable Growth with a Projected CAGR of 13.4% by 2033

The global antibody therapy market is on the brink of unprecedented expansion, driven by advancements in immunotherapy and the rising demand for innovative treatments for critical diseases such as cancer and COVID-19. A recent market analysis projects a robust Compound Annual Growth Rate (CAGR) of 13.4% from 2023 to 2033, propelling the market’s value to an impressive USD 824.0 billion by 2033, up from USD 235 billion in 2023.

The increasing prevalence of life-threatening conditions has accelerated the adoption of antibody therapies, offering a more effective and less invasive alternative to traditional chemotherapy. Patients suffering from cancer and other immune-related diseases are increasingly opting for monoclonal antibody therapy, which serves as a form of passive immunotherapy. This treatment enhances the immune system’s ability to combat diseases by generating new cells and strengthening the body’s natural defenses, resulting in improved patient outcomes with fewer side effects.

As healthcare systems worldwide recognize the potential of antibody therapies, significant advancements in cell therapy, particularly in cancer treatment, have emerged. These advancements are contributing to the rapid growth of the antibody therapy market, as healthcare providers continue to embrace these cutting-edge therapeutic options.

Moreover, the market is witnessing a surge in research and development activities, leading to the introduction of novel cancer and cell therapy techniques. The growing popularity of therapeutic antibody derivatives further enriches the market landscape, creating a favorable environment for continued innovation and growth.

The remarkable growth trajectory of the antibody therapy market underscores its critical role in transforming disease management and treatment paradigms. With a steadfast commitment to innovation, stakeholders across the healthcare ecosystem are poised to unlock new avenues for enhancing patient outcomes and quality of life.

Key Points:

The United States market leads the space in terms of market share and CAGR. The market is expected to cross a value of USD 291.9 billion by 2033. The regional market is expected to thrive at a CAGR of 13.1% between 2023 and 2033.
The Chinese antibody therapy market is another significant Asian market. It thrives at a steady CAGR of 12.7% during the forecast period. The market is likely to reach a value of USD 59.1 billion by 2033. Asian economies like India and China are building their healthcare infrastructure by advancing them with the latest therapeutic solutions to high-risk diseases like cancer.
Monoclonal antibodies are likely to thrive in the antibody type category, as it provides immediate and short-term immunity from conditions like COVID-19. It is expected to thrive at a CAGR of 13.2% during the forecast period.
The hospital segment leads the end-user category with a CAGR of 12.6% between 2023 and 2033. The growth is attributed to the bigger budget, higher patient traffic, and easy availability of therapeutic experts.

The Latest Reports from Get Old Source Are Here

Competitive Landscape:

The key competitors create better packages with advanced cell-therapy solutions that deliver treatment with lesser side effects and higher effectiveness. Key competitors also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market are: F. Hoffmann-La Roche Ltd., AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc.

For instance:

Amgen Inc. has introduced its monoclonal antibody that holds bioengineered molecules, specially designed to target protein involved in different types of diseases.
AbbVie Inc. has launched the first fully human monoclonal antibody, along with the antibody drug conjugates, that applies the target of an antibody that delivers a therapeutic agent. The company’s other research targets include interleukin-1, interleukin-23, and JAK (Janus Kinase Inhibitors)

Key Segments:

By Type:

Monoclonal Antibodies
- Oncology, Autoimmune Disease
- Infectious Disease
- Other
Antibody Drug Conjugates

By End User:

Hospitals
Specialty Centers
Others

By Region

North America
Latin America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pet Diabetes Care Devices Market Set to Reach USD 4.3 Billion by 2033, Driven by Growing Adoption in Veterinary Clinics

The global pet diabetes care devices market is experiencing significant growth, with a current valuation of USD 2.3 billion in 2023 and an anticipated increase to USD 4.3 billion by 2033. This growth, fueled by a robust Compound Annual Growth Rate (CAGR) of 6.2% over the forecast period, underscores the expanding demand for advanced pet healthcare solutions.

Veterinary clinics are at the forefront of this market expansion, playing a pivotal role in driving the adoption of pet diabetes care devices. Healthcare professionals and animal caretakers within these clinics are increasingly recommending and utilizing these devices to enhance the management of pet health. These advanced devices are critical for detecting, monitoring, and managing common health issues in pets, thereby preventing complications and ensuring better overall care.

The rising awareness among pet owners, coupled with the proactive approach of veterinary clinics, is significantly boosting the adoption of diabetes care devices. By integrating these devices into routine care, pet owners can effectively manage their pets’ health, leading to an improved quality of life for their beloved companions.

Pet diabetes care devices, including insulin pens, glucose monitoring systems, and glucose meters, are designed in various sizes and shapes, featuring advanced functionalities for ease of use. Veterinary clinics not only inform pet owners about their pets’ conditions but also guide them on the benefits and usage of these devices. Additionally, they educate pet owners on the importance of providing nutritious food and regularly monitoring blood glucose levels.

With the number of pets diagnosed with diabetes on the rise, the demand for pet diabetes care devices is surging. Veterinary clinics are instrumental in expanding the market by offering pet owners effective tools to support their pets’ health conditions, providing comprehensive training on the use of these devices, and ensuring regular monitoring at home.

The global pet diabetes care devices market is poised for continued growth as veterinary clinics continue to champion advanced pet health management solutions, empowering pet owners to take charge of their pets’ well-being.

Key Takeaways:

The pet diabetes care devices market is registering a CAGR of 6.2% with a valuation of USD 4.3 billion by 2033.
In the historical period, the market captured a CAGR of 5.7%, with a valuation of USD 1.7 billion in 2018.
The United States is a prominent leader in the global market, registering a share of 27% during the forecast period.
China is one of the significant countries in the Asia Pacific that securing a CAGR of 8.20% by 2033.
During the forecast period, India is registering a CAGR of 7.50% in the global market.

Find the Freshest Reports from Get Old Source

How Key Players are Focus on Adding Values in the Global Market?

Key players are focusing on innovating pet diabetes care devices by adding advanced features resulting in accuracy, convenience, and ease to use. The key players are deploying small sensors in these devices to monitor pets’ health conditions, such as blood glucose levels. These devices work on a real-time basis as pet owners track the condition of their pets and provide them with healthy nutrition with a proper dietary plan.

The key players developing specially design insulin syringes to provide more accurate information than other devices. These devices provide quick results, increasing the adoption of pet healthcare to treat pets’ poor health conditions. Conversely, guiding pet owners, growing awareness, and innovating easy-to-access pet care devices improve pet health.

Recent Developments in the Global Pet Diabetes Care Devices Market are:

In September 2021, Zoetis Inc launched its new product VETSCAN IMAGYST. This device offers to monitor pets’ diabetes and health conditions.
In July 2021, Merck Animal Health launched Vetsulin to manage pets’ diabetes.
In 2020, IDEXX Laboratories announced its new product device IDEXX SDMA Test to identify kidney disease in cats and dogs and also the complication of diabetes.
In 2019, Vetoquinol announced its acquisition with Epitopix to provide vaccination for diabetes-diagnosed pets.

Other Essential Players in the Global Market are:

Abbot Laboratories, Inc
Virbac
Medtronic plc
Johnson & Johnson Services, Inc
Roche Diagnostics
Bio-Rad Laboratories, Inc
Novo Nordisk A/S
Zoetis Inc
Terumo Corporation
Boehringer Ingelheim International GmbH
IDEXX Laboratories
Johnson & Johnson Services, Inc
Terumo Corporation
Eli Lilly and Company
Vetoquinol S.A.

Pet Diabetes Care Devices Market by Category:

By Animal Type:

Cats
Dogs
Horses

By Device:

Insulin Delivery Devices
Insulin Delivery Pen
Insulin Syringes
Glucose Monitoring Devices

By End User:

Veterinary Clinics
Home Care Settings
Veterinary Hospitals

Region:

North America
Europe
Latin America
Asia Pacific
The Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Pharmaceutical Lactose Market Forecast: Projected to Hit USD 392.3 Million by 2033 | Future Market Insights Inc.

The pharmaceutical lactose market growth can be attributed to the rising demand for orally disintegrating tablets (ODTs), as lactose acts as an excellent carrier for such formulations. Additionally, lactose’s biocompatibility and biodegradability enhance its appeal for use in various drug delivery systems. As the pharmaceutical industry focuses on patient-centric formulations, lactose aids in improving taste, texture, and stability of oral medications, ultimately enhancing patient compliance.

According to Future Market Insights’ latest analysis, the global pharmaceutical lactose Industry size is expected to reach US$ 222.6 million in 2023 and further expand at 5.8% CAGR throughout the forecast period (2023 to 2033). Overall sales of pharmaceutical lactose are projected to total a valuation of US$ 392.3 million in 2033.

Rising application of lactose as an ideal excipient across thriving pharmaceutical sector is a prominent factor driving the global market forward. Similarly, increasing prevalence of chronic diseases, development of new medicines, and increased investment in research & development are expected to facilitate expansion of the worldwide pharmaceutical lactose industry.

Over the years, lactose has become one of the most commonly used excipients in the pharmaceutical sector for producing a wide range of solid dosage forms. It finds application as a binder, carrier, or diluent and helps pharmaceutical companies to produce tablets of sufficient hardness.

Rising production and consumption of solid dosage forms such as capsules and tablets is expected to boost pharmaceutical lactose demand during the forecast period. Subsequently, growing demand for dry powder inhalation products will create growth opportunities for pharmaceutical lactose manufacturers.

Various forms of lactose i.e., α-lactose monohydrate, β-lactose, amorphous lactose, and spray dried lactose are being employed for manufacturing drugs.

Increasing healthcare awareness, especially across developing regions, growing popularity of preventive healthcare, and rising healthcare spending are expected to further expand the pharmaceutical lactose Industry size over the next ten years.

Key Takeaways from the Pharmaceutical Lactose Market Study:

Pharmaceutical lactose market is projected to surge at a CAGR of about 8% over the next ten years in Mexico.
By product type, α-lactose monohydrate segment will continue to lead the global pharmaceutical lactose Industry during the forecast period.
The United Kingdom pharmaceutical lactose market is anticipated to exceed a valuation of US$ 184.8 million by 2033.
The USA is anticipated to hold around 78.3% share of North America pharmaceutical lactose market in 2023.
Mexico is poised to hold around 5.3% of the global pharmaceutical lactose market by 2033.

Who is Winning?

DFE Pharma, Ba’emek Advanced Technologies Ltd (Tnuva Group), Avantor, Inc., Alpavit Käserei Champignon Hofmeister GmbH & Co. KG, Lactose (India) Limited, Hoogwegt Groep B.V., Hilmar Ingredients, Armor Pharma, Merck KgaA, Kerry plc, Milei GmbH, BASF SE, MEGGLE Excipients & Technology are few of the leading companies present in the global pharmaceutical lactose market.

Key pharmaceutical lactose companies are focusing on partnerships and joint ventures to expand their product portfolio and strengthen their supply chain.

Get Valuable Insights into Pharmaceutical Lactose Market

Future Market Insights, in its new offering, provides an unbiased analysis of the pharmaceutical lactose Industry presenting historical demand data (2018 to 2022) and forecast statistics for the period from (2023 to 2033). The study divulges compelling insights on the demand based on product type (β-Lactose, α-Lactose monohydrate, Amorphous lactose, Spray dried lactose) and region.

About the Food & Beverage Division at Future Market Insights

Expert analysis, actionable insights, and strategic recommendations- the food & beverage team at Future Market Insights helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Thorough Market Evaluation: Get Full Report

Pharmaceutical Lactose Market by Category

Product Type:

β-lactose
α-Lactose monohydrate
Amorphous Lactose
Spray Dried Lactose

Region:

North America
Latin America
Europe
East Asia
South Asia
Middle East and Africa
Oceania

About Future Market Insights (FMI)

Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Hemophilia Treatment Market to Reach USD 18.7 Billion by 2034 at a CAGR of 4.4%

The global hemophilia treatment market is set for significant growth, with forecasts predicting a rise from USD 12.1 billion in 2024 to USD 18.7 billion by 2034, representing a compound annual growth rate (CAGR) of 4.4% over the next decade. This surge is driven by advancements in treatment options and increased access to innovative therapies.

Hemophilia, a life-threatening disorder characterized by a deficiency of clotting proteins in the blood, leads to excessive and uncontrollable bleeding. Preventative treatments, such as regular injections of clotting factors, play a crucial role in reducing the frequency and severity of bleeding episodes, particularly in patients with hemophilia A. These treatments not only enhance the body’s ability to form clots but also significantly improve the quality of life for those affected by the disease.

Treatment options for hemophilia include component replacements derived from human plasma as well as recombinant products. These therapies work by increasing the clotting factors in the body, thus promoting better clot formation and minimizing bleeding risks. Healthcare providers typically prescribe either prophylactic or episodic treatments, depending on the patient’s needs. Prophylactic treatments aim to prevent bleeding episodes before they occur, while episodic treatments are administered in response to a bleeding event. The ability for patients to perform infusions at home has further revolutionized hemophilia care, enabling more effective and efficient management of the condition.

One of the most promising developments in hemophilia treatment is gene therapy, an area of ongoing research and innovation. In recent years, the FDA has approved gene therapy treatments for both hemophilia A and hemophilia B, marking a significant milestone in the field. These genetic therapies have the potential to provide long-term solutions for hemophilia patients by addressing the underlying genetic causes of the disease and supplying the missing clotting factors for an extended period.

As the global hemophilia treatment market continues to expand, the focus remains on developing more effective and accessible treatments that can improve the lives of patients worldwide. With ongoing advancements in gene therapy and other innovative approaches, the future of hemophilia treatment holds great promise.

“Advancements in treatment and revolutionary approaches to gene therapies have driven hemophilia treatment demand to unprecedented heights. Developments in diagnostics and ongoing developments in hemophilia treatments are expected to expand the market for hemophilia treatments in years ahead.” – Says an analyst at FMI.

Key Takeaways from the Hemophilia Treatment Market:

Historically, hemophilia treatment generated a 4.1% CAGR from 2019 to 2023.
Through 2034, the United States and Canada market is expected to experience a CAGR of 2%.
It is anticipated that India will exhibit a CAGR of 7.4% during the forecast period.
Between 2024 and 2034, China’s market is expected to expand at a CAGR of 6.5%.
Based on drug class, prophylaxis accounted for 68.7% of the market in 2023.

Explore Comprehensive Findings: Find the Full Report on the Hemophilia Treatment Market

Competitive Landscape:

Hemophilia treatment companies are actively investing in research and development in order to introduce novel therapies to the global market. As part of their growth strategy, these companies are implementing acquisitions, mergers, product developments and approvals, collaborative ventures, etc.

Recent Development:

In February 2023, Octapharma USA filed a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) expanding the approval of wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection, aimed at reducing bleeding in children and adults with von Willebrand disease (VWD).
In December 2023, Global biotechnology leader CSL released its three-year results for its pivotal HOPE-B study, showing that HEMGENIX® (etranacogene dezaparvovec-drlb) was effective in treating hemophilia B in patients who received a one-time infusion. At the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, data showing that one-time infusions of HEMGENIX increase factor IX activity levels for years were presented.

Key Players of the Hemophilia Treatment Industry:

Hoffmann-La Roche Ltd
Octapharma
CSL Behring
Sanofi
Bayer AG
Baxter
Swedish Orphan Biovitrum AB
Grifols International S.A
Kedrion

Hemophilia Treatment Market Segmentation

By Drug Class:

In terms of drug class, the industry is divided into clotting factors (recombinant factor concentrates, plasma-derived factors concentrate), monoclonal antibodies, antidiuretic and antihemorrhagic drugs, aminocaproic acid, antifibrinolytic agents, and gene therapy.

By Indication:

In terms of indication, the industry is segregated into a hemophilia A, hemophilia B, and Von Willebrand disease.

By Distribution Channel:

In terms of distribution channel, the industry is segmented into hospitals, specialized clinics, retail pharmacies, and mail order pharmacies.

By Region:

Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia, East Asia, Middle East, and Africa have been covered in the report.

About Future Market Insights (FMI)

Contact Us:

Plant-Based Butter Market Overview: Detailed Segmentation, Applications, and Technological Advancements to 2030

The growing popularity of plant-based butter has led to specialty brands experimenting with new flavors and sources. A new study by Future Market Insights concurs with positive consumer sentiment on plant-based butter, estimating market to grow nearly 7% y-o-y in 2021. Sales of vegan foods and beverages have gone up significantly owing to increased health awareness among consumers, especially in terms of effects from the consumption of animal-based products. The broader gains in the plant-based food category have rubbed off on varied categories, with plant-based butter sales gaining significant traction.

As per the Food Industry Association, around 30% of households are home to vegan, vegetarian, flexitarian, or pescatarian consumers. This trend is creating opportunities for growth for plant-based butter manufacturers. Demand for plant-based butter can also be attributed to the growing consumer preference for clean-label, natural foods, which is pushing dairy producers to develop and launch vegan alternatives.

Key Takeaways Global plant-based butter market to exhibit CAGR exceeding 7.5% through 2030 Soy-milk based butter held nearly 40% share in 2020 Online retail distribution to register relatively faster growth, aided by benefits in terms of consumer engagement US to remain the largest market, pegging North America to surpass US$ 200 Mn in 2020“The plant-based butter market is a nascent phase and is being increasingly viewed as a high-potential product in the dairy alternative industry, as a healthy alternative to conventional fatty food products, which will aid growth in the market for the foreseeable future,” says a FMI analyst.

Covid-19 Impact AnalysisThe covid-19 pandemic has resulted in substantial changes in the dietary preferences of consumers around the world. Concerns over transmission of the virus through animal based products has aided the adoption of plant-based alternatives.

Also, plant-based butter can be sourced from oat milk, rice milk, corn milk, soy milk, pea milk, almond milk, coconut milk, cashew milk, flax milk, and hemp milk among others, allowing for a wider flavor range. While demand from the food service sector is likely to drop owing to lockdown restrictions, home consumption with sales through online sales is expected to rise.

The prospects of the plant-based butter market has widened since early 2020. As per the Good Food Institute, sales of plant-based foods surpassed that of animal based alternatives since the advent of the crisis, and will continue through the forecast period.

Who is Winning?The plant-based butter market is competitive and characterized by the presence of small and mid-scale players. Leading manufacturers are effectively leveraging demand for natural, clean label products, with the aim of geographic expansion and widening product portfolios for long term growth.

Some of the leading players in the plant-based butter market include Conagra Brands Inc., Upfield Foods, Miyoko’s Creamery, Wayfare Food, Prosperity Organic Food Inc., Lyrical Foods Inc., Califia Farms, Premier Organics, Naturli Foods, Ekogram-the real food, Wildfriend Foods, The J.M. Smuker Co., The Leaviet Corp., Milkadamia, among others.

Exhaustive Market Report: A Complete Study

More Valuable Insights on Plant-based Butter Market

Source

Oat Milk Rice Milk Corn Milk Soy Milk Pea Milk Almond Milk Coconut Milk Cashew Milk Flax Milk Hemp Milk Others

Distribution Channel

B2B Hotels Restaurants Cafes B2C Hypermarket/Supermarket Convenience Stores Specialty Stores Mom and Pop Stores Discount Stores Food & Drink Specialty Stores Independent Small Groceries Online Retail Others

Region

North America (U.S. & Canada) Latin America (Mexico & Rest of LATAM) Europe, Middle East & Africa Asia Pacific (Greater China, South East Asia, Japan, India, South Korea, Australia, New Zealand)

Frequently Asked Questions

How will the plant-based butter market expand through 2030?
Which is the largest plant-based butter market?
How is COVID-19 impacting the plant-based butter growth projections?
Which are some of the prominent market players?

About Future Market Insights (FMI)

Contact FMI:

Global Plastic Caps & Closures Market to be Worth USD 76,953.0 Million by 2033: Future Market Insights, Inc.

The global plastic caps & closures market size is slated to surpass a valuation of USD 45,913.6 million in 2023. FMI anticipates the market is estimated to attain a valuation of USD 76,953.0 million by 2033. The market is predicted to showcase a CAGR of 5.3% from 2023 to 2033.

For packing and closing various kinds of bottles, tubes, containers, and jars, plastic caps, and closures provide a reliable and secure packaging option. Thermoplastic and thermoset plastics are the materials used to make plastic caps and closures.

Plastic caps and closures are great for packaging a range of carbonated and non-carbonated beverages as well as industrial items since they are lightweight and recyclable.

Gain Comprehensive Knowledge—Read the Entire Report Now!

The increasing number of millennials in emerging nations and their increasing disposable incomes drive the consumption of carbonated and non-carbonated drinks. Due to shifting inclinations toward healthy lifestyles, the market for plastic caps & closures has experienced notable expansion.

The demand for plastic caps and closures is expected to increase as consumers turn to convenient packaging options.

The United States is anticipated to be a significant growth region during the forecast period. The rising product innovations, expanding food and beverage industry, and growing demand for bottled water are expected to bolster regional market growth.

Key Takeaways from Plastic Caps & Closures Market:

In 2018, the global plastic caps & closures market size stood at USD 36,420.4 million.
The market size valued at USD 43,602.7 million in 2022.
The market expanded at a considerable CAGR of 4.6% from 2018 to 2022.
In 2022, the screw closures segment captured 71.0% market share.
Thermoplastics accounted for nearly 97% of the total plastic caps & closures market in 2022.
In 2022, the beverage segment captured 49.1% market share.
In 2022, the United States accounted for 18.9% market share.

Competitive Landscape

The top and small-scale producers in the global market are focused on the changing industry needs of the end user and manufacturing accordingly. Key market players are implementing market strategies such as product portfolio expansions and mergers and acquisitions to increase their business reach and market position.

Key Players in the Global Market

Berry Global Inc.
Amcor Plc
Silgan Plastics
Aptar Inc.
O.Berk Company LLC
Bericap GmbH & Co KG
UNITED CAPS
CL Smith Company
Closure Systems International Inc.
BLACKHAWK MOLDING CO. Inc.
Georg MENSHEN GmbH & Co. KG
Mold-Rite Plastic LLC
Plasticap Inc.
Guala Closures S.p.A.
Weener Plastik GmbH

Recent Developments Observed by FMI:

For the Estathè brand of sweet tea soft drinks from Ferrero, Aptar debuted a new practical product packaging in May 2023. To package Estathè, Ferrero used an Aptar Rocket sports hat.
In March 2023, United Caps introduced a brand-new tethered closure for a carton packing. The Tamper-Evident (TE) band included in the new 23 H-PAK tethered solution keeps all components whole for quick recycling and is easy to incorporate with existing practices.
Mespack and Hoffer introduced spout and cap closure in January 2023. The new closure uses 20% less plastic and is comprised of a monolayer material.
Silgan Plastics, a top provider of eco-friendly rigid packaging solutions, purchased Gateway Plastics in September 2021. Gateway Plastics makes dispensing closures and offers integrated dispensing packaging solutions to the food and beverage industry.
In June 2021, Mala Verschluss-Systeme GmbH was bought by BERICAP, a well-known producer of plastic closures. Manufacturers of aluminum closures include Mala. With the purchase of Mala, BERICAP might expand its product line to include aluminum closures and create cutting-edge closure solutions that combine plastic and aluminum.
Aptar Global, Inc. debuted PolkaLite, a new product category, in January 2022. PolkaLite is a closure that performs better and is convenient since it is light.

Plastic Caps & Closures Market Segmentation

By Caps Type:

Screw Closures
Snap Closures
Push-Pull Closures
Others

By Material Type:

Thermoplastic
- PE
  - LDPE/LLDPE
  - HDPE
- PP
- Others (PS, PET, etc.)
Thermosets

By End-use:

Beverage
Food
Pharmaceutical
Household
Cosmetics & Personal Care
Others (Chemicals, Fertilizers, etc.)

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vegan Supplements Market to Reach USD 14.1 Billion by 2032, Future Market Insights Reports

The Vegan Supplements market has experienced a remarkable surge in recent years, driven by a growing global trend towards plant-based diets and increasing awareness of environmental and ethical concerns. These products are designed to provide essential nutrients, vitamins, and minerals without any animal-derived ingredients, catering to the needs of individuals following a vegan lifestyle or those seeking cruelty-free alternatives.

The global vegan supplements market is expected to develop at a CAGR of 11.3% from 2022-2032. It is anticipated to reach a valuation of approximately US$ 14,089.6 Mn by the end of 2032.

The market for vegan supplements is expected to grow at a fast pace from 2022 to 2032 as a result of rising concerns regarding animal health and protection on one side, and rising veganism on the other side. A strict vegetarian diet that forgoes all animal products, including milk, eggs, and meat, is known as a vegan diet. The global acceptance of vegan supplements, which have a high nutritional content, is a consequence of the beverages and food industry’s ongoing transformation.

Vitamins for vegetable lovers are nowadays much more necessary than ever. Consumers’ rising levels of healthy lifestyle consciousness and the rapidly expanding vegetarian population continue to be key drivers. It is founded on component labeling and the promotion of contributions that are high in energy.

Key Takeaways from the Vegan Supplements Market Study

Approximately 40% of consumers in the U.S. bought vegan products because they believe these products are nutritious.
By form, the powder segment is expected to remain at the forefront by generating the largest vegan supplements market share.
Nearly 75% of German households would want to see more vegetarian goods at supermarkets.
Europe is estimated to drive demand in the vegan supplements market during the forecast period of 2022 to 2032.
The vegan supplements market is expected to reach nearly US$ 4,803.6 Mn by 2022.

“Rising adoption of preventive healthcare practices and increasing prevalence of vitamin deficiencies are expected to bode well for the global vegan supplements market. Manufacturers and retailers are beginning to provide free access to “wellness tools” that would create a user-specific antioxidants list based on their specific requirements and conditions,” says a Future Market Insights analyst.

Competitive Landscape: Vegan Supplements Market

Some of the key players are General Mills Inc., Garden of Life, Danone S.A., PepsiCo Inc. , Blue Diamond Growers Inc, ALOHA, NuGo Nutrition, One Brands, BHU Foods , G&G Foods, Country Life LLC, Wonder Laboratories, Now Health Group Inc., Jarrow Formulas, Kerry Group PLC, Nutritional Growth Solution, and others.

The global vegan supplements industry is moderately competitive and fragmented, with several mid and small-scale businesses. Key players operating in the global market are focusing on continuous product launches and new product developments to stay ahead in competition.

Explore More Valuable Insights on the Vegan Supplements Market

Future Market Insights, in its new report, offers an impartial analysis of the global vegan supplements market, presenting historical data (2017-2021) and estimation statistics for the forecast period of 2022-2032.

The study offers compelling insights based on the form (powder, liquid, capsules & soft gels, tablets, pills, gummies, and bars), based on ingredients (vitamins & minerals, amino acids & proteins, herbal & botanical ingredients, and others), based on health needs (weight loss, sports nutrition, general well-being, immune & digestive health, bone & joint health, heart health, and other specific requirements), based on customer orientation (men, women, senior citizen, and others), and based on sales channel (hypermarkets/supermarkets, pharmacies & drug stores, convenience stores, departmental stores, online retail stores and other sales channel), across seven major regions of the world.

Detailed Market Study: Full Report and Analysis

Vegan Supplements Market Outlook by Category

By Form:

Powder
Liquid
Capsules & Soft Gels
Tablet
Pills
Gummies
Bars

By Ingredients:

Vitamins & Minerals
Amino Acids & Proteins
Herbals & Botanicals
Others

By Health Needs:

Weight Loss
Sports Nutrition
General Well-being
Immune & Digestive Health
Bone & Joint Health
Heart Health
Other Specific Requirements

By Customer Orientation:

Men
Women
Senior Citizen
Others (Kids & Toddlers)

By Sales Channel:

Hypermarkets/Supermarkets
Pharmacies & Drug Stores
Convenience Stores
Departmental Stores
Online Retail Stores
Other Sales Channel

About Future Market Insights (FMI)

Contact FMI:

Algae Fats Industry Expected to Grow to USD 484.5 Million by 2033, According to FMI

The global algae fats market is expected to reach a market valuation of US$ 297.7 million in 2023, accelerating with a CAGR of 5% from 2023 to 2033. The growing demand for algae-based products in various industries such as food, animal feed, and biofuel is driving the growth of the algae fats market.

One of the key drivers of the algae fats industry is the growing demand for sustainable and plant-based products. Algae fats are considered to be a healthier alternative to animal fats and are rich in essential fatty acids such as omega-3 and omega-6. Furthermore, the increasing awareness about the environmental impact of traditional animal-based fats and oils is also driving the demand for algae fats as they are considered to be eco-friendly.

Despite the growing demand, the algae fats industry faces several challenges. One of the key restraints is the high production cost of algae fats. The technology for large-scale production of algae fats is still in its nascent stage, and the production process requires a significant investment in infrastructure, equipment, and technology. Additionally, the limited availability of suitable land and freshwater resources for algae cultivation is also a significant restraint for industry.

Opportunities and Trends Hovering the Algae Fats Industry

The algae fats industry presents significant opportunities for growth and innovation. One key opportunity is the development of new products and applications for algae fats. Algae fats are already being used in various industries, such as food, animal feed, dietary supplements, and biofuels. However, the industry can further explore new applications such as cosmetics, pharmaceuticals, and industrial lubricants. Furthermore, the increasing investment in R&D activities and technological advancements can lead to the development of new and cost-effective production processes.

The algae fats industry is witnessing several trends that are expected to shape the market in the coming years. One of the key trends is the increasing adoption of algae-based biofuels. Algae-based biofuels are considered to be a sustainable and eco-friendly alternative to traditional fossil fuels. Furthermore, the growing demand for algae-based dietary supplements and functional foods is also a key trend in the industry. The use of algae fats in the animal feed industry is also expected to witness significant growth due to the increasing demand for high-quality and sustainable animal feed products.

Key Takeaways from the Algae Fats Market:

With an estimated market share of roughly 55% in 2023, the food-grade sector is likely to dominate the industry.
In terms of end-use, the dietary supplement sector is predicted to have the greatest market share in 2023, accounting for around 45% of the market.
The animal feed segment is another prominent market segment, with a market share of roughly 30% projected in 2023.
The algae fats industry in the United States dominated the global market in 2022, accounting for 22.9% of the total.
In 2022, Germany’s algae fats industry held a 3.6% share.
The algae fats industry in India is predicted to grow at the fastest rate of 20.1% between 2023 and 2033.
The algae fats industry in China is predicted to grow at a 5.0% CAGR between 2023 and 2033.
From 2023 to 2033, the algae fats industry in the United Kingdom is predicted to grow at a 6.7% CAGR.

How Industry Players are Revolutionizing the Competitive Landscape?

The algae fats industry is highly competitive, with several key players vying for market share. Some of the leading companies in this market include Corbion, TerraVia, Royal DSM, Archer Daniels Midland Company, and BASF SE. These companies have established themselves as leaders in the industry by offering a wide range of products and solutions to meet the growing demand for algae fats.

Corbion, for instance, has a strong presence in the food and beverage industry, with a portfolio that includes algae-based ingredients such as AlgaPrime DHA. TerraVia, on the other hand, has a focus on sustainable products and solutions, with its flagship product, AlgaWise, being a high-performance oil with a low environmental footprint.
Royal DSM is another key player in the algae fats industry, with a broad portfolio of products for various applications. The company has a focus on innovation, with ongoing research and development efforts to improve the sustainability and functionality of its products.
Archer Daniels Midland Company is a leading supplier of ingredients for various industries, including the food, beverage, and animal feed sectors. The company offers a range of algae-based ingredients, such as omega-3 oils, which are used in dietary supplements, infant formulas, and other applications.

Comprehensive Market Insights: Full Report Overview

Algae Fats Market: Segmentation

By Type:

Food Grade
Feed Grade

By End Application:

Biofuel
Dietary Supplement
Animal Feed

About Future Market Insights (FMI)

Contact FMI:

Global Infertility Treatment Market Surpasses, Projected to Exceed USD 3.5 Billion by 2032

The global infertility treatment market has reached a monumental milestone, exceeding a value of over USD 1.5 billion in 2021. This significant achievement underscores the resilience of the industry and its promising outlook for the future. With a robust Compound Annual Growth Rate (CAGR) of 8% projected from 2022 to 2032, experts forecast the market to surpass an impressive USD 3.5 billion valuation by the end of this period.

This remarkable growth is fueled by the increasing demand for advanced infertility treatments, driven by a global rise in infertility rates. As individuals and couples worldwide face the challenges of infertility, the industry has responded with innovative solutions, particularly in Assisted Reproductive Technology (ART). These advancements reflect a commitment to addressing the evolving needs of patients and ensuring access to effective treatment options.

Key Factors Driving Market Growth:

Rising Global Infertility Rates: The significant increase in infertility rates worldwide has prompted a growing number of individuals and couples to seek advanced and effective treatment options. This trend highlights the crucial need for accessible and innovative solutions, leading to substantial investments in research and development within the industry.
Demand for Advanced Treatments: As patients seek higher success rates and improved outcomes, the demand for advanced infertility treatments continues to rise. This desire for cutting-edge technologies and procedures is positioning the market for ongoing expansion and development.
Focus on Innovation: The industry’s unwavering commitment to innovation remains a key growth driver. Recent advancements in Assisted Reproductive Technologies (ART) and other treatment options empower healthcare providers to deliver exceptional patient care, further propelling the market forward.

The global infertility treatment market’s sustained growth is a testament to the industry’s dedication to improving patient outcomes and addressing the growing demand for effective solutions. As the market continues to evolve, the focus on innovation and patient-centric care will remain at the forefront of its expansion.

Key Takeaways: Infertility Treatment Market

The global infertility treatment market is booming, expected to reach USD 3.5 billion by 2032, growing at a healthy 8% annually.
The UK leads the market due to declining fertility rates, numerous clinics, and popularity of assisted reproductive technologies (ART) like IVF.
The US market is also strong with rising infertility (e.g., PCOS), a rapidly evolving healthcare system, and wider adoption of advanced fertility treatments.
Increasing PCOS cases in the US are a key driver, affecting 6-12% of reproductive-aged women.
Advanced options like donor egg IVF and ART procedures like IVF and GIFT are gaining traction due to their higher success rates.

Access Detailed Market Data: Download the Complete Infertility Treatment Market Report Now

Competitive Landscape:

Leading infertility treatment providers are continually expanding their product offerings and services to attract more customers. They have adopted various strategies to gain a competitive edge in the global infertility treatment market, such as partnerships, acquisitions, mergers, collaborations, awareness campaigns, advertisements, and establishing new treatment centers and clinics. For instance:

In August 2021, Merck Specialties Pvt Ltd launched the Pergoveris Pen for advanced infertility treatment in India.
In 2022, Vios Fertility Institute, in partnership with TMRW Life Sciences, introduced state-of-the-art cryo management solutions for fertility specimens.

Key Companies Covered:

Thermo Fisher Scientific (USA)
Cook Group (USA)
Vitrolife (Sweden)
IVFtech APS (Denmark)
Hamilton Thorne Ltd. (USA)
Esco Micro Pte Ltd. (Singapore)
Genea Biomedx Ltd. (Australia)
FUJIFILM Irvine Scientific (USA)
Baker Company INC. (USA)

Key Segments:

By Product:

Equipment
- Microscopes
- Imaging Systems
- Sperm Analyser Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
- Sperm Separation Devices
Media & Consumables
Accessories

By Procedure:

Assisted Reproductive Technology
- In Vitro Fertilization
  - Intracytoplasmic Morphologically Selected Sperm Injection
  - Gamete Donation
- Intracytoplasmic Sperm Injection
- Surrogacy
Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intratubal Insemination
Fertility Surgeries
- Laparoscopy
- Hysteriscopy
- Varicocelectomy
- Laparotomy
- Tubal Ligation Reversal
- Microsurgical Reconstruction
  - Vasovasostomy
  - Vasoepididymostomy
Other Infertility Treatment Procedures

By Patient Type:

Female Infertility Treatment
Male Infertility Treatment

By End User:

Fertility Centres
Hospitals & Surgical Clinics
Cryobanks
Research Institutes

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Dairy Ingredients Market to Grow at 6% CAGR by 2033: Industry Forecast and Analysis

The dairy ingredients market is predicted to grow at a CAGR of 6% over the forecast period, according to FMI’s analysis. The industry’s value is anticipated to increase from US$ 66 Billion in 2023 to US$ 118 Billion by 2033 end.

The dairy ingredients market is strongly supported by the largest contribution of the U.S. market. All 50 states in America have dairy farms, and almost 95% of them are owned by family businesses. The milk that they produce is used by large corporates to process, package, and create other dairy products like cheese and yogurt. High demand for dairy products and ingredients due to the escalating number of netizens and easily accessible health and diet information is propelling the market.

The wide range of applications of dairy ingredients in bakeries and confectionery is boosting the dairy ingredients market. High consumption of confections that include dairy ingredients like milk chocolate, caramel, fudge, pralines, and toffee, is stimulating the demand for dairy ingredients. The category growth is forecast to be fueled by demand for premium indulgent chocolates. Chocolates are available both as an affordable routine snack and luxury gifting items. Promising growth opportunities for this segment are expected to strongly influence the scope of dairy ingredients manufacturers.

Latest News Pertaining to the Developments by Dairy Ingredients Key Players:

In 2021, Eurial I&N introduced EuriNutri WPC, a whey protein concentrate ingredient that has about 80% of protein content. The product is suitable for post-effort recovery and pre-workout nutrition.
In 2020, Arla Foods unveiled its first organic ingredient, MicelPure, which is a micellar casein isolate. The ingredient includes at least 87% of native milk protein and has low lactose and fat content.
In 2020, Lactalis Ingredients released a new skimmed milk powder, which has excellent heat stable qualities. The product is ideal for formulating condensed milk. It is developed in Lactalis plant located in Germany.

Key Takeaways from the Dairy Ingredients Market:

The United States dairy ingredients market is predicted to hold major share in the global market. As per FMI’s estimated, the market worth would stand at a lucrative US$ 41.8 Bn by 2033. Over the coming years, the market would accelerate at 5.8% CAGR.
After U.S., China would lead the global market by achieving the market size of US$ 8.5 Bn by 2033. In the span of next 10 years, the Chinese market would expand at a CAGR of 5.5%.
Under the product type category, the proteins segment holds the largest market share. This could be attributed to the rising health-conscious consumers who are incorporating proteins in their diet by consuming dairy products or protein supplements. The segment is forecast to grow at a CAGR of 5.9%.
The growing preference for powdered dairy ingredients due to extended shelf-life and wide applicability is propelling dairy ingredients market. The powdered form of dairy ingredients is predicted to grow at a CAGR of 5.6%.

Key Segments

By Product Type:

Proteins
Milk Powder
Milk Fat Concentrates
Casein and Caseinates
Lactose & Its Derivatives
Whey
Other Types

By Form Type:

Powder
Liquid

By Application:

Bakery & Confectionery
Dairy Products
Sports Nutrition Products
Infant Formulas
Cosmetics
Pharmaceuticals
Other Applications

By Distribution Channel:

E-Commerce
Specialty Retailers
Supermarket & Hypermarket
Others

By Region:

North America (U.S & Canada)
Latin America (Brazil, Mexico, Argentina & Rest of Latin America)
Europe (Germany, Italy, France, U.K., Spain & Rest of Europe)
South Asia & Pacific (India, Thailand, Indonesia, Malaysia, Australia & New Zealand and Rest of South Asia & Pacific)
East Asia (China, Japan & South Korea)
Middle East & Africa (GCC, South Africa, Israel & Rest of MEA)

In-Depth Market Analysis: A Complete Report

Frequently Asked Questions

How will the global dairy ingredients market expand in the future?
What drivers underpin the global dairy ingredients market growth?
Which is the most prominent dairy ingredient type?
Which is the largest dairy ingredient market?
Which are the prominent dairy ingredients market players?

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: